Neoangiogenesis contributes to the development of hemophilic synovitis
Open Access
- 24 February 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (8), 2484-2493
- https://doi.org/10.1182/blood-2010-05-284653
Abstract
Joint arthropathy secondary to recurrent hemarthroses remains a debilitating complication of hemophilia despite the use of prophylactic factor concentrates. Increased vascularity and neoangiogenesis have been implicated in the progression of musculoskeletal disorders and tumor growth. We hypothesized that de novo blood vessel formation could play a major role in the pathogenesis of hemophilic joint disease (HJD). We observed a 4-fold elevation in proangiogenic factors (vascular endothelial growth factor-A [VEGF-A], stromal cell–derived factor-1, and matrix metalloprotease-9) and proangiogenic macrophage/monocyte cells (VEGF+/CD68+ and VEGFR1+/CD11b+) in the synovium and peripheral blood of HJD subjects along with significantly increased numbers of VEGFR2+/AC133+ endothelial progenitor cells and CD34+/VEGFR1+ hematopoietic progenitor cells. Sera from HJD subjects induced an angiogenic response in endothelial cells that was abrogated by blocking VEGF, whereas peripheral blood mononuclear cells from HJD subjects stimulated synovial cell proliferation, which was blocked by a humanized anti-VEGF antibody (bevacizumab). Human synovial cells, when incubated with HJD sera, could elicit up-regulation of HIF-1α mRNA with HIF-1α expression in the synovium of HJD subjects, implicating hypoxia in the neoangiogenesis process. Our results provide evidence of local and systemic angiogenic response in hemophilic subjects with recurrent hemarthroses suggesting a potential to develop surrogate biologic markers to identify the onset and progression of hemophilic synovitis.Keywords
This publication has 42 references indexed in Scilit:
- Synovial Hypoxia as a Cause of Tendon Rupture in Rheumatoid ArthritisThe Journal of Hand Surgery, 2008
- Arthroscopic synovectomy in haemophilia: indications, technique and resultsHaemophilia, 2007
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancerGynecologic Oncology, 2006
- Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cellsLeukemia, 2006
- Synovitis in a murine model of human factor VIII deficiencyHaemophilia, 2005
- Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantationThrombosis and Haemostasis, 2004
- Advances in Care of Children with HemophiliaSeminars in Thrombosis and Hemostasis, 2003
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis & Rheumatism, 2001
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesPublished by Elsevier BV ,1997